Boostrixtetra Drug Information [ GlaxoSmithKline ]

Table of content

Boostrixtetra category:

• Human

Active ingredients:

• Bordetella Pertussis Toxoid
• Diphtheria Toxoid
• Filamentous Haemagglutinin Bordetella Pertussis
• Pertactin
• Poliomyelitis Virus Type 1 Inactivated
• Poliomyelitis Virus Type 2 Inactivated
• Poliomyelitis Virus Type 3 Inactivated
• Tetanus Toxoid

Boostrixtetra companies and manufacturers:

• GlaxoSmithKline

General Information

Boostrixtetra forms, composition and dosages:

• Injectable; Injection; Diphtheria Toxoid 2 IU; Bordetella Pertussis Toxoid 8 mcg; Filamentous Haemagglutinin Bordetella Pertussis 8 mcg; Pertactin 2.5 mcg; Poliomyelitis Virus Type 1 Inactivated 40 units; Poliomyelitis Virus Type 1 Inactivated 8 units; Poliomyelitis Virus Type 1 Inactivated 32 units; Tetanus Toxoid 20 IU

Indications, usages and classification codes:

• ATC
• ICD-10

• Boostrixtetra analogs
• Boostrixtetra similar